M&A
-
How Do American and European Biotech Companies Make Money Using Chinese New Drugs? Sharing Successful Cases of LIDLO, LIDMA, and LIDIPO
Welcome friends to share your views in the comments section! DrugTimes will continue to pay close attention and follow up on the reports
-
After ten years, Merck returns to the field of ophthalmology with a $3 billion investment!
Congratulations to Merck and EyeBio!
